A Retrospective Natural History Study of Patients With Lysosomal Acid Lipase Deficiency/Wolman Phenotype

Study Identifier:
LAL-1-NH01
ClinicalTrials.gov Identifier:
NCT01358370
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Study Complete

Study Details

Medical Condition
  • Unmapped
Study Drug
    Date
    Nov 2010 - Jan 2013
    Phase 1
    Phase 2
    Phase 3
    Phase 4
    N/A
    Patient Requirements
    Sex: Female & Male
    Age: N/A - N/A
    Requirements Information
    Sex
    Female & Male
    Age
    N/A - N/A

    Study Details

    Medical Condition
    • Unmapped
    Study Drug
      Date
      Nov 2010 - Jan 2013
      Phase 1
      Phase 2
      Phase 3
      Phase 4
      N/A
      Patient Requirements
      Sex: Female & Male
      Age: N/A - N/A years
      Requirements Information

      Protocol Summary

      This is a Natural History study to characterize key aspects of the clinical course of lysosomal acid lipase (LAL) deficiency/Wolman phenotype in patients.

      Trial Locations

      Location
      Status
      Location
      Cedars-Siani Medical Center
      Los Angeles, California, United States, 90095-1752
      Status
      N/A
      Location
      Stanford University
      Palo Alto, California, United States, 94305
      Status
      N/A
      Location
      University of Minnesota
      Minneapolis, Minnesota, United States, 55455
      Status
      N/A
      Location
      Columbia University
      New York, New York, United States, 10027
      Status
      N/A
      Location
      Ney York Presbyterian Hosptial
      New York, New York, United States, 10032
      Status
      N/A
      Location
      North Shore Long Island Jewish Medical Center
      New York, New York, United States, 11040
      Status
      N/A